US$ 20.45
glp-1 intestinal paralysis lawsuit in michigan Wegovy class has higher GI side effect risk than older weight loss drug study Severe Stomach Paralysis Linked to
Description
Rapid weight loss raises cholelithiasis risk

In 2024, Chinese firms accounted for a third of Big Pharma out-licensing deals, 85% of which were involved antibody-drug conjugates

(1987) Truncated glucagon-like peptide I, an insulin-releasing hormone from the distal gut

Gong et al., 2014b)
1 Previously, multiple other GLP-1 agonists reached the public (Table 1)
